[1]
“Removing the Roadblocks in Equitable Global Access to COVID-19 Vaccine through IPR Waiver”, JIPR, vol. 27, no. 3, pp. 163–170, Jul. 2023, doi: 10.56042/jipr.v27i3.64890.